IDT and Bioscience Announce Comprehensive Strategic Partnership to Accelerate Local Innovation in China

Global OligonucleotidesInnovatorIntegrated DNA Technologies(hereinafter referred to as “IDT”)withShanghaiBioscienceTechnology Co., Ltd.(hereinafter referred to as "Bioscience")TodayOfficial AnnouncementComprehensive SigningStrategic CooperationProtocol, Accelerating the Implementation of Localized Innovation Projects in China。

Since April 2025,Shanghai Bioscience Co.,Ltd. will integrate the technological advantages of Integrated DNA Technologies with its own localization capabilities, assume full responsibility for the operation of IDT’s core product lines, and build a new business ecosystem through innovative models such as talent exchange and joint R&D.This deepened collaboration marks a key milestone in the development of life sciences research and precision medicine in China, and will significantly drive innovative development and technological breakthroughs in the industry.

In recent years, driven by the combined forces of policy, technology, capital, and talent, China’s precision medicine and molecular biology sectors have experienced rapid development, with sustained growth in market demand for advanced technologies, high-quality products, and efficient delivery.

IDT, leveraging its core strengths in oligo design and synthesis,ConstructedComplete Product Portfolio from Research Use Only (RUO) to cGMPSystem，We offer a diverse range of modified primers and probes, high-quality next-generation sequencing (NGS) library preparation kits for targeted sequencing, cutting-edge solutions for small nucleic acids (such as ASOs and DsiRNAs), and innovative CRISPR/Cas genome editing products, thereby delivering comprehensive solutions that span genetic testing, functional genomics, and cell and gene therapy (CGT).

Mr. Peng Yang, Global Vice President of Danaher Corporation and President of Danaher China, stated, “This collaboration between Danaher Corporation and Bioscience embodies the ‘Launching China’ strategy,”Unveiling the grand opening of IDT’s localization in China, it has pioneered a new model of cooperation between Danaher Group and domestic enterprises."I firmly believe that the cooperation between both parties will surely bear fruitful results."

Mr. Hu Xiangyu, President of Danaher’s Life Sciences Platform in China, stated: “As a strategic distributor for Danaher Corporation, Shanghai Bioscience Co., Ltd. has established an extensive foundation for collaboration with multiple operating companies within the Danaher Life Sciences platform."This strategic collaboration with IDT China not only marks a significant new milestone in our partnership, but also represents a strategic initiative by both parties to align with the rapid development of China’s life sciences industry and jointly unlock the potential of the Chinese market."

Mr. Wu Jianhua, General Manager of IDT China, stated: “This collaboration with BioscienceDemonstrating IDT’s commitment to its roots in China, this marks the accelerated expansion of IDT China in the field of localized innovation., leveraging the advantages of China-made agility, a people-centric philosophy, and channel resources, while integrating IDT’s industry-leading high-quality products such as oligonucleotides, we will once again drive product upgrades and technological innovation in the industry. We look forward to our collaboration delivering more timely and higher-quality services to customers in China.”

In his address, Mr. Liu Pei, Chairman of Shanghai Bioscience Co., Ltd., emphasized: “Shanghai Bioscience has always taken the Danaher Business System (DBS) as its benchmark, implementing the advanced concepts of lean management,”Pioneered the Bioscience Business System (BBS), characterized by Shanghai Bioscience, to continuously improve production quality.“It is a great honor to join hands with IDT, a global innovator in the field of oligonucleotides. We believe this collaboration will inject strong momentum into the rapid advancement of precision medicine and cell and gene therapies in China.”

Danaher is an innovator in life sciences and medical diagnostics, dedicated to accelerating scientific progress and improving human health. We collaborate closely with our customers to address the many critical health challenges facing patients worldwide. Danaher’s advanced science and technology, combined with its proven innovation capabilities, not only enable faster and more accurate medical diagnostics but also effectively reduce time and costs, thereby facilitating the sustainable discovery, development, and delivery of life-changing therapies. Guided by a commitment to scientific excellence, innovation, and continuous improvement, Danaher’s approximately 63,000 associates worldwide help enhance the quality of life for billions of people today while laying the foundation for a healthier, more sustainable future.

Integrated DNA Technologies, Inc. (IDT) is an operating company within the Life Sciences platform of Danaher Corporation (NYSE: DHR). IDT is dedicated to developing, manufacturing, and selling nucleic acid products for the life sciences community, supporting academic and commercial research, agriculture, medical diagnostics, and drug development. IDT has developed multiple proprietary technologies for genomic applications, covering next-generation sequencing, CRISPR genome editing, synthetic biology, digital PCR, and RNA interference. Through its GMP services, IDT’s products are used by scientists to study various forms of cancer as well as genetic and infectious diseases. As a leading manufacturer in custom nucleic acid production, IDT serves over 130,000 life science researchers. Founded in 1987, IDT is headquartered in Coralville, Iowa, USA, with manufacturing facilities in San Diego, California; Research Triangle Park, North Carolina; Leuven, Belgium; and Singapore.

Shanghai Bioscience Co., Ltd., established in 2005, is a platform-based service provider specializing in the life sciences sector. With over 60,000 clients, more than 600 employees, and 26 offices/branches, the company offers millions of products. Guided by its mission to “Serve Science,” Shanghai Bioscience has built a multi-dimensional product portfolio tailored to diverse research and production scenarios. It has established strategic partnerships with global industry leaders such as Danaher Corporation and maintains close collaborations with more than 20 mainstream life science brands, empowering researchers to achieve greater breakthroughs in life science exploration. “Bioscience Youpin” is the umbrella brand for Shanghai Bioscience’s proprietary products, encompassing four major categories: laboratory instruments, consumables, reagents, and technical services. Upholding the company’s enduring commitment to innovation and focus, Bioscience Youpin leverages its own technology center and production supply chain system to deliver high-quality, one-stop laboratory solutions to life science professionals worldwide.

Reposting Notice: Reposting requires authorization from marketing@bioscience.com.cn. Any form of modification, abridgment, or tampering is strictly prohibited; violators will be held legally accountable.